Literature DB >> 17919313

Assessment of potential risk factors associated with ischaemic colitis.

L Chang1, K H Kahler, C Sarawate, R Quimbo, J Kralstein.   

Abstract

Ischaemic colitis (IC) has been associated with a number of diverse disorders and risk factors, including irritable bowel syndrome (IBS) and constipation. We sought to assess, through a large-scale population study, the potential risk factors associated with IC. Patients with IC and matched controls without IC were identified using the medical and pharmacy claims data from the HealthCore Managed Care Database from 1st January 2000 to 31st May 2005. A multivariate conditional logistic regression model was developed to identify significant risk factors of IC. Interactions of age, sex, prior IBS diagnosis, and prior constipation diagnosis were further evaluated. We identified 1754 patients with IC and 6970 non-IC controls; 64% were women, and mean ages were 63 and 62 years respectively. The final parsimonious model comprised 19 independent variables associated with increased risk for IC including shock, dysentery, bloating, IBS, colon carcinoma, constipation, cardiovascular disease, dyspepsia, abdominal, aortic, or cardiovascular surgery, 12-month laxative, H(2) receptor blocker and oral contraceptive use. A significant interaction was observed between age and prior IBS on risk for IC. In conclusion, multiple risk factors for IC were identified and we confirmed that patients with IBS or constipation are at greater risk for IC.

Entities:  

Mesh:

Year:  2007        PMID: 17919313     DOI: 10.1111/j.1365-2982.2007.01015.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  23 in total

1.  Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron.

Authors:  Susan Lucak
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.

Authors:  Kenneth Tong; Jean Paul Nicandro; Reshma Shringarpure; Emil Chuang; Lin Chang
Journal:  Therap Adv Gastroenterol       Date:  2013-09       Impact factor: 4.409

3.  ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI).

Authors:  Lawrence J Brandt; Paul Feuerstadt; George F Longstreth; Scott J Boley
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

4.  Early Endoscopy Is Associated with Better Clinical Outcomes in Patients Hospitalized with Ischemic Bowel Disease.

Authors:  Olalekan Akanbi; Adeyinka Charles Adejumo
Journal:  Dig Dis Sci       Date:  2019-03-30       Impact factor: 3.199

Review 5.  The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.

Authors:  James H Lewis
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

6.  A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitis.

Authors:  Siddhant Yadav; Maneesh Dave; Jithinraj Edakkanambeth Varayil; W Scott Harmsen; William J Tremaine; Alan R Zinsmeister; Seth R Sweetser; L Joseph Melton; William J Sandborn; Edward V Loftus
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-12       Impact factor: 11.382

Review 7.  Management of ischemic colitis.

Authors:  Christopher Washington; Joseph C Carmichael
Journal:  Clin Colon Rectal Surg       Date:  2012-12

8.  Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats.

Authors:  Evelin Painsipp; Anaid Shahbazian; Peter Holzer
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Endoscopic findings and clinicopathologic characteristics of ischemic colitis: a report of 85 cases.

Authors:  Xiaoping Zou; Jun Cao; Yulin Yao; Wenjia Liu; Longdian Chen
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

10.  Update on the Diagnosis and Management of Colon Ischemia.

Authors:  Ann D Flynn; John F Valentine
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.